DK481480A - Fremgangsmaade til dyrining af hepatitis b virus - Google Patents

Fremgangsmaade til dyrining af hepatitis b virus

Info

Publication number
DK481480A
DK481480A DK481480A DK481480A DK481480A DK 481480 A DK481480 A DK 481480A DK 481480 A DK481480 A DK 481480A DK 481480 A DK481480 A DK 481480A DK 481480 A DK481480 A DK 481480A
Authority
DK
Denmark
Prior art keywords
hepatitis
virus
animalization
procedure
liver tissue
Prior art date
Application number
DK481480A
Other languages
English (en)
Inventor
M R Hilleman
P M Keller
W J Mcaleer
P J Provost
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK481480A publication Critical patent/DK481480A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK481480A 1979-11-13 1980-12-12 Fremgangsmaade til dyrining af hepatitis b virus DK481480A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9365879A 1979-11-13 1979-11-13

Publications (1)

Publication Number Publication Date
DK481480A true DK481480A (da) 1981-05-14

Family

ID=22240085

Family Applications (1)

Application Number Title Priority Date Filing Date
DK481480A DK481480A (da) 1979-11-13 1980-12-12 Fremgangsmaade til dyrining af hepatitis b virus

Country Status (9)

Country Link
EP (1) EP0028987B1 (da)
JP (1) JPS5682089A (da)
AT (1) ATE8108T1 (da)
DE (1) DE3068373D1 (da)
DK (1) DK481480A (da)
ES (1) ES8200398A1 (da)
GR (1) GR71857B (da)
IE (1) IE50339B1 (da)
PT (1) PT72015B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US4416986A (en) * 1981-01-16 1983-11-22 Merck & Co., Inc. Methods of producing HBsAg
CA2244709A1 (en) * 1996-01-29 1997-08-07 Kye-Hyung Paik Method of protein production using mitochondrial translation system
GB9815939D0 (en) * 1998-07-23 1998-09-23 Univ Leicester Hepatitis B culture system
US6562562B2 (en) * 2000-03-10 2003-05-13 Pharmacia & Upjohn S.P.A. Procedure for partial liver resection in nonhuman primates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS48103722A (da) * 1972-04-15 1973-12-26
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro

Also Published As

Publication number Publication date
IE802329L (en) 1981-05-13
EP0028987A2 (en) 1981-05-20
ES496780A0 (es) 1981-11-01
IE50339B1 (en) 1986-04-02
ATE8108T1 (de) 1984-07-15
GR71857B (da) 1983-07-05
ES8200398A1 (es) 1981-11-01
JPH042231B2 (da) 1992-01-16
DE3068373D1 (en) 1984-08-02
EP0028987A3 (en) 1982-05-19
JPS5682089A (en) 1981-07-04
PT72015A (en) 1980-12-01
EP0028987B1 (en) 1984-06-27
PT72015B (en) 1982-06-20

Similar Documents

Publication Publication Date Title
DK0747485T3 (da) Fremstilling af proteiner ved anvendelse af homolog rekombination
ATE2014T1 (de) Lebendes, attenuiertes virus des hepatitis a beim menschen, verfahren zu seiner zuechtung in zellkultur in vitro und dieses virus enthaltende zusammensetzung.
DK0414475T3 (da) Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
FI930206A (fi) Adoptiv immunoterapi med interleukin-7
DK372780A (da) Fremgangsmaade til propagering af humant hepatitis a virus
ATE7855T1 (de) Herstellung von virusantigenen.
DE69333855D1 (de) Aus einer mit einem Stamm von Multiple-Sklerosis-Virus infizierten Zellinie hergestelltes biologisches Virusmaterial
ES504199A0 (es) Un metodo para aumentar el rendimiento de vha en un cultivo celular in vitro
DK481480A (da) Fremgangsmaade til dyrining af hepatitis b virus
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
ATE10806T1 (de) Verfahren zur herstellung von hepatitis boberfl[chenantigen.
ATE361975T1 (de) Tiermodell für hepatitis-virus infektion
ATE87653T1 (de) Immortalisierung durch dns-uebertragung.
GB1105179A (en) Improvements in or relating to propagating human hepatitis virus
KR900001374A (ko) Bu-3608을 이용한 인체면역결핍 바이러스에 대한 항바이러스 방법
SU1565021A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus - продуцент моноклональных антител к вирусу ящура 0-01618
FR2585722B1 (fr) Co-cultures d'hepatocytes et de cellules epitheliales de foie traitees
SU1692147A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура cn 564

Legal Events

Date Code Title Description
ATS Application withdrawn